SHFP
RMD icon

Second Half Financial Partners’s ResMed RMD Stock Holding History

Second Half Financial Partners’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,029
Closed -$235K – 95
2024
Q4 		$235K Sell
1,029
-1,115
-52% -$268K 0.12% 84
2024
Q3 		$523K Buy
+2,144
New +$479K 0.28% 57

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Second Half Financial Partners's RMD Position: Q1 2025 in Review

Second Half Financial Partners sold out of ResMed (RMD) in Q1 2025, closing a stake of 1,029 shares — an estimated $235K sold.

Second Half Financial Partners first reported a position in RMD in Q3 2024 and held it in 2 quarters. The position peaked at $523K in Q3 2024. 885 funds tracked by Wall St. Rank hold RMD as of Q1 2025.

  • Second Half Financial Partners reported no remaining ResMed position as of Q1 2025 after selling out during the quarter.
  • Second Half Financial Partners sold 1,029 ResMed shares in Q1 2025, an estimated $235K.
  • Second Half Financial Partners first reported a position in ResMed in Q3 2024 and held it in 2 quarters.
  • Second Half Financial Partners's ResMed position peaked at $523K in Q3 2024.
  • 885 funds tracked by Wall St. Rank held ResMed as of Q1 2025.

Based on Second Half Financial Partners's 13F filing for Q1 2025, filed 7 May 2025.